1. Home
  2. AVBP vs IGIC Comparison

AVBP vs IGIC Comparison

Compare AVBP & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • IGIC
  • Stock Information
  • Founded
  • AVBP 2021
  • IGIC 2001
  • Country
  • AVBP United States
  • IGIC Jordan
  • Employees
  • AVBP N/A
  • IGIC N/A
  • Industry
  • AVBP
  • IGIC Property-Casualty Insurers
  • Sector
  • AVBP
  • IGIC Finance
  • Exchange
  • AVBP NYSE
  • IGIC Nasdaq
  • Market Cap
  • AVBP 879.2M
  • IGIC 1.0B
  • IPO Year
  • AVBP 2024
  • IGIC N/A
  • Fundamental
  • Price
  • AVBP $21.75
  • IGIC $24.87
  • Analyst Decision
  • AVBP Strong Buy
  • IGIC Buy
  • Analyst Count
  • AVBP 5
  • IGIC 2
  • Target Price
  • AVBP $39.40
  • IGIC $31.50
  • AVG Volume (30 Days)
  • AVBP 172.1K
  • IGIC 85.1K
  • Earning Date
  • AVBP 03-03-2025
  • IGIC 05-06-2025
  • Dividend Yield
  • AVBP N/A
  • IGIC 0.40%
  • EPS Growth
  • AVBP N/A
  • IGIC 16.99
  • EPS
  • AVBP N/A
  • IGIC 2.98
  • Revenue
  • AVBP N/A
  • IGIC $539,000,000.00
  • Revenue This Year
  • AVBP N/A
  • IGIC N/A
  • Revenue Next Year
  • AVBP N/A
  • IGIC $6.00
  • P/E Ratio
  • AVBP N/A
  • IGIC $8.54
  • Revenue Growth
  • AVBP N/A
  • IGIC 7.95
  • 52 Week Low
  • AVBP $14.35
  • IGIC $12.73
  • 52 Week High
  • AVBP $36.37
  • IGIC $27.76
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 32.12
  • IGIC 45.48
  • Support Level
  • AVBP $21.34
  • IGIC $23.78
  • Resistance Level
  • AVBP $22.75
  • IGIC $25.69
  • Average True Range (ATR)
  • AVBP 1.40
  • IGIC 1.13
  • MACD
  • AVBP -0.14
  • IGIC -0.13
  • Stochastic Oscillator
  • AVBP 8.41
  • IGIC 27.39

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

Share on Social Networks: